ClinicalTrials.Veeva

Menu

Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients

Zhejiang University logo

Zhejiang University

Status

Not yet enrolling

Conditions

Ulcerative Colitis
Inflammatory Bowel Diseases
Crohn Disease

Treatments

Other: education ,psycological support and social support

Study type

Interventional

Funder types

Other

Identifiers

NCT05719766
20230049

Details and patient eligibility

About

This study aims to prospectively explore the effect of incentive-integrated E-IBD (electronic inflammatory bowel disease) chronic disease management model on the improvement of IBD quality of life, and provide a more effective chronic disease management model for improving the quality of life and social participation of IBD patients.The investigators firstly identify the IBD patients in need of empowerment disease activities through the questionnaire .Then, the investigators feedback the patients' education content according to their needs found.Based on the social support network of patient organization and the medical support network of tertiary medical institutions, the investigators complete the empowerment process of IBD patients' self-management initiative and self-management ability, through the internet. Finally ,the investigators evaluate the quality of life(QoL), social participation,disease self-management level via questionnaire . The primary outcome is the improvement of QoL score after three months' intervention.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1.Clinically diagnosed IBD patients,according to the criteria of the Inflammatory Bowel Group of the Gastroenterology Branch of the Chinese Medical Association in 2018;
  • 2.Aged 18 to 75 years old;
  • 3.Understand and comply with the requirements of the program and sign informed consent.
  • 4.Identified as need intervention according to the patient identification questionnaire screening;
  • 5.Patients with the ability to complete all course training and/or follow-up work;
  • 6.Enrolled at least one year ahead of end of this study(for garantee of enough folllow-up time).

Exclusion criteria

  • 1.Unable or unwilling to sign the consent form, or unable to follow the research procedure;
  • 2.Patients who have had a stoma or ileorectal anastomosis (partial scales are not available);
  • 3.Patients who do not complete training on time or do not complete follow-up assessments in their entirety;
  • 4.Patients with other malignancies or life-threatening complications;
  • 5.Pregnancy or lactation;
  • 6.Patients whose remaining follow-up time less than one year before the end of this study.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

Routine follow-up group
No Intervention group
IBD Disease Management Research Group
Experimental group
Treatment:
Other: education ,psycological support and social support

Trial contacts and locations

4

Loading...

Central trial contact

Shiyuan Lu, PhD; Yan chen, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems